*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.
Idexx Laboratories, a leader in veterinary diagnostics, is poised for its upcoming earnings release on November 3, 2025, with analysts projecting an EPS of $3.14 and revenue of $1.07 billion. Despite the absence of recent news, the company's robust market cap of over $51 billion underscores its strong position in the industry. Investors are keenly watching for any signs of strategic shifts or innovations that could drive future growth. The whisper number of $3.45 suggests that market expectations are slightly more optimistic than the consensus, indicating confidence in Idexx's ability to outperform. As the company continues to capitalize on its expertise in animal health, any updates on new product launches or market expansions could further bolster investor sentiment.
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets.
Website: https://www.idexx.com
Average Sentiment Score:
Overall Sentiment: